Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
96.706,90
-0,51%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ iTeos Therapeutics Inc (ITOS) iTeos Therapeutics Inc (ITOS) Notizie

iTeos Therapeutics Inc

ITOS
7,4501
0,2301 (3,19%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/12/202414:55GLOBEiTeos Therapeutics Presents Interim A2A-005 Clinical Trial..
07/12/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202413:00GLOBEiTeos to Participate in Upcoming Investor Conferences
20/11/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202415:57EDGAR2Form SC 13D/A - General Statement of Acquisition of..
12/11/202413:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202413:00GLOBEiTeos Reports Third Quarter 2024 Financial Results and..
04/11/202413:00EDGAR2Form 8-K - Current report
24/10/202413:00GLOBEiTeos Therapeutics to Highlight Inupadenant Preclinical,..
21/10/202422:11EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
16/9/202413:00EDGAR2Form 8-K - Current report
14/9/202408:30GLOBEiTeos Announces Clinically Meaningful Objective Response..
28/8/202422:30GLOBEiTeos to Participate in Upcoming Investor Conferences
20/8/202414:30GLOBEiTeos Therapeutics Announces Late-Breaking Oral Presentation..
10/8/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202413:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:00GLOBEiTeos Reports Second Quarter 2024 Financial Results and..
05/8/202413:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202413:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/8/202413:00GLOBEiTeos Therapeutics Announces Appointment of David Feltquate..
08/7/202413:00GLOBEiTeos Announces First Patient Dosed in GALAXIES Lung-301..
17/6/202415:00GLOBEiTeos and GSK Initiate GALAXIES Lung-301 Phase 3 Study,..
14/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202422:01EDGAR2Form 8-K - Current report
13/5/202413:01EDGAR2Form 8-K - Current report
10/5/202422:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/5/202414:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202414:26GLOBEiTeos Reports First Quarter 2024 Financial Results and..
10/5/202414:24GLOBEiTeos Therapeutics Announces $120 Million Registered Direct..
07/4/202422:30GLOBEiTeos Presents EOS-984 Preclinical Data Demonstrating..
09/3/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202401:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202401:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202402:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/3/202413:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/3/202413:09EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202413:01GLOBEiTeos Appoints Oncology Veteran Jill DeSimone to Its Board..
06/3/202413:00GLOBEiTeos Reports Fourth Quarter and Full Year 2023 Financial..
05/3/202422:30GLOBEiTeos to Highlight Preclinical Data on First-In-Class..
01/3/202413:00GLOBEiTeos to Participate in Upcoming Investor Conferences
10/1/202423:00EDGAR2Form 8-K - Current report
08/1/202413:00GLOBEiTeos Announces 2024 Strategic Priorities and Anticipated..
03/1/202413:00GLOBEiTeos to Present at the 42nd Annual J.P. Morgan Healthcare..
Apertura: 7,17 Min: 7,09 Max: 7,51
Chiusura: 7,22

La tua Cronologia

NASDAQ
ITOS
iTeos Therapeutics
LSE
34VJ
Municplty 39
BIT
S32519
Societe Generale Effekten
BIT
SLVR
WisdomTree Silver
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network